The Potentiality of Prostate-Specific Antigen as a Prognostic Biomarker in Breast Cancer.

Bouaod, Wedad; Zakoko, Ahmed M; Asif, Hamza; Hussain, Azhar; Malik, Nadia; Ray, Sidhartha D; Peela, Jagannadha; Teja Peela, Anirudh Srinivas; Jarari, Abdalla M

Bouaod, Wedad; Zakoko, Ahmed M; Asif, Hamza; Hussain, Azhar; Malik, Nadia; Ray, Sidhartha D; Peela, Jagannadha; Teja Peela, Anirudh Srinivas; Jarari, Abdalla M.

Affiliation

Bouaod W; Biochemistry, Benghazi Medical Center, Benghazi, LBY.
Zakoko AM; Biochemistry, Benghazi Medical Center, Benghazi, LBY.
Asif H; Medicine, St. George's University - School of Medicine, Princeton, USA.
Hussain A; Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, New York, USA.
Malik N; Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, New York, USA.
Ray SD; Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, New York, USA.
Peela J; Biochemistry and Genetics, St. Matthew's University School of Medicine, Grand Cayman, CYM.
Teja Peela AS; General Surgery, NRI Institute of Medical Sciences, Visakhapatnam, IND.
Jarari AM; Biochemistry, Benghazi Medical Center, Benghazi, LBY.

Cureus ; 15(9): e44621, 2023 Sep.

Article de En | MEDLINE | ID: mdl-37799254

Mots clés

breast cancer; ca125; ca19.9; free psa; hematological biomarker; prostate-specific antigen (psa)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Cureus Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google